T. Ming Chu

7.7k total citations · 2 hit papers
113 papers, 5.5k citations indexed

About

T. Ming Chu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, T. Ming Chu has authored 113 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 39 papers in Oncology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in T. Ming Chu's work include Monoclonal and Polyclonal Antibodies Research (25 papers), Prostate Cancer Treatment and Research (22 papers) and Glycosylation and Glycoproteins Research (19 papers). T. Ming Chu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (25 papers), Prostate Cancer Treatment and Research (22 papers) and Glycosylation and Glycoproteins Research (19 papers). T. Ming Chu collaborates with scholars based in United States, France and Japan. T. Ming Chu's co-authors include Susan S. Leong, Julius S. Horoszewicz, Elzbieta Kawinski, G.P. Murphy, James P. Karr, E. A. Mirand, Hannah Rosenthal, G P Murphy, Lawrence D. Papsidero and Luis Valenzuela and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Development.

In The Last Decade

T. Ming Chu

111 papers receiving 5.2k citations

Hit Papers

LNCaP model of human prostatic carcinoma. 1980 2026 1995 2010 1983 1980 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Ming Chu United States 35 2.4k 2.3k 1.3k 723 719 113 5.5k
Julius S. Horoszewicz United States 21 1.5k 0.6× 1.6k 0.7× 791 0.6× 470 0.7× 482 0.7× 57 3.7k
Christopher S. Foster United Kingdom 46 3.9k 1.6× 2.8k 1.2× 1.7k 1.3× 546 0.8× 1.9k 2.6× 150 7.4k
Pradip Roy‐Burman United States 42 3.4k 1.4× 1.6k 0.7× 1.3k 1.0× 261 0.4× 837 1.2× 125 6.0k
Young E. Whang United States 39 3.2k 1.3× 1.5k 0.7× 1.7k 1.3× 322 0.4× 874 1.2× 101 5.6k
H Magdelénat France 42 2.3k 0.9× 916 0.4× 2.1k 1.6× 412 0.6× 1.7k 2.4× 158 5.5k
Thomas Meyer Switzerland 45 3.7k 1.5× 887 0.4× 2.2k 1.6× 576 0.8× 668 0.9× 137 7.9k
Janet E. Price United States 48 3.7k 1.5× 1.0k 0.4× 3.2k 2.4× 548 0.8× 1.5k 2.1× 136 7.5k
Eliot M. Rosen United States 57 4.7k 1.9× 999 0.4× 1.8k 1.3× 480 0.7× 1.2k 1.7× 145 7.9k
Fabien Calvo France 45 3.3k 1.4× 606 0.3× 2.3k 1.8× 298 0.4× 790 1.1× 160 6.7k
Kotoku Kurachi United States 48 4.4k 1.8× 840 0.4× 1.1k 0.8× 339 0.5× 1.2k 1.7× 114 8.6k

Countries citing papers authored by T. Ming Chu

Since Specialization
Citations

This map shows the geographic impact of T. Ming Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Ming Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Ming Chu more than expected).

Fields of papers citing papers by T. Ming Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Ming Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Ming Chu. The network helps show where T. Ming Chu may publish in the future.

Co-authorship network of co-authors of T. Ming Chu

This figure shows the co-authorship network connecting the top 25 collaborators of T. Ming Chu. A scholar is included among the top collaborators of T. Ming Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Ming Chu. T. Ming Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tokhunts, Robert, Samer Singh, T. Ming Chu, et al.. (2009). The Full-length Unprocessed Hedgehog Protein Is an Active Signaling Molecule. Journal of Biological Chemistry. 285(4). 2562–2568. 38 indexed citations
2.
Chu, T. Ming, et al.. (2006). A C-Terminal Motif Targets Hedgehog to Axons, Coordinating Assembly of the Drosophila Eye and Brain. Developmental Cell. 10(5). 635–646. 34 indexed citations
3.
Chu, T. Ming, et al.. (2001). Cortex, a Drosophila gene required to complete oocyte meiosis, is a member of the Cdc20/fizzy protein family. genesis. 29(3). 141–152. 52 indexed citations
4.
Chen, Bin, et al.. (2000). Completion of meiosis in Drosophila oocytes requires transcriptional control by Grauzone, a new zinc finger protein. Development. 127(6). 1243–1251. 25 indexed citations
5.
Chu, T. Ming & Ming Lin. (1998). PSA and acid phosphatase in the diagnosis of prostate cancer. 21(1). 24–34. 23 indexed citations
6.
Chu, T. Ming & Elzbieta Kawinski. (1998). Plasmin, Substilisin-like Endoproteases, Tissue Plasminogen Activator, and Urokinase Plasminogen Activator Are Involved in Activation of Latent TGF-β1in Human Seminal Plasma. Biochemical and Biophysical Research Communications. 253(1). 128–134. 50 indexed citations
7.
Chu, T. Ming. (1997). Prostate-Specific Antigen and Early Detection of Prostate Cancer. Tumor Biology. 18(2). 123–134. 34 indexed citations
8.
Chu, T. Ming. (1997). Molecular diagnosis of pancreas carcinoma. Journal of Clinical Laboratory Analysis. 11(4). 225–231. 19 indexed citations
9.
Chu, T. Ming, Tsung H. Lin, & Elzbieta Kawinski. (1994). Detection of Soluble P-Glycoprotein in Culture Media and Extracellular Fluids. Biochemical and Biophysical Research Communications. 203(1). 506–512. 18 indexed citations
10.
Chu, T. Ming, et al.. (1990). Prostate-Specific Antigen: Questions Often Asked. Cancer Investigation. 8(1). 27–37. 12 indexed citations
11.
Piver, M. Steven, et al.. (1988). Serum α1-acid glycoprotein in epithelial ovarian cancer. Gynecologic Oncology. 29(3). 305–308. 9 indexed citations
12.
Kadohama, N., et al.. (1987). Immunotherapy in a spontaneously developed murine mammary carcinoma with syngeneic monoclonal antibody. Cancer Immunology Immunotherapy. 25(2). 93–9. 15 indexed citations
13.
Chu, T. Ming, et al.. (1984). Immunologically reactive tryptic fragments of human prostatic acid phosphatase. Biochemical Journal. 223(3). 871–877. 6 indexed citations
14.
Gibbons, Robert P., S. Beckley, Mark F. Brady, et al.. (1983). The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate. Journal of Surgical Oncology. 23(2). 133–142. 11 indexed citations
15.
Slack, Nelson H., et al.. (1981). Carcinoplacental isoenzyme (regan) in carcinoma of the prostate. Cancer. 47(1). 146–151. 8 indexed citations
16.
Slack, N.H., James P. Karr, T. Ming Chu, & G.P. Murphy. (1980). An assessment of bone scans for monitoring osseous metastases in patients being treated for prostate carcinoma. The Prostate. 1(2). 259–270. 17 indexed citations
17.
Chu, T. Ming, E. Douglas Holyoke, & Harold O. Douglass. (1980). Tumor antigens as related to pancreatic cancer. Journal of Surgical Oncology. 13(3). 207–214. 3 indexed citations
18.
Vincent, R. G., et al.. (1978). Carcinoembryonic antigen as a monitor of successful surgical resection in 130 patients with carcinoma of the lung. Journal of Thoracic and Cardiovascular Surgery. 75(5). 734–739. 20 indexed citations
19.
Chu, T. Ming, A. K. Bhargava, Eric A. Barnard, et al.. (1975). Tumor antigen and acid phosphatase isoenzyme in prostatic cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 59(1). 97–103. 13 indexed citations
20.
Vincent, R. G. & T. Ming Chu. (1973). Carcinoembryonic antigen in patients with carcinoma of the lung. Journal of Thoracic and Cardiovascular Surgery. 66(2). 320–328. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026